Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala

Neuropharmacology

Volumn 49, Issue 6, 2005, Pages 737-749

  Mazei Robison, Michelle S ^a   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Dopamine; Polymorphism; Protein kinase C; Regulation; Transporter

Indexed keywords

ALANINE; DOPAMINE TRANSPORTER; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN; CELL STRAIN COS7; CELL SURFACE; GENE ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENETIC CODE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALANINE; AMPHETAMINE; ANIMALS; BIOTINYLATION; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; COCAINE; COS CELLS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, BIOLOGICAL; MUTAGENESIS; NEUROBLASTOMA; NOREPINEPHRINE; PHORBOL ESTERS; PROTEIN TRANSPORT; RATS; TIME FACTORS; TRANSFECTION; VALINE; VARIATION (GENETICS);

EID: 26944469588     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.08.012     Document Type: Article

References (59)

1. S. Apparsundaram, A. Galli, L.J. DeFelice, H.C. Hartzell, and R.D. Blakely Acute regulation of norepinephrine transport: I. PKC-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells Journal of Pharmacology and Experimental Therapeutics 287 1998 733 743
2. S. Apparsundaram, U. Sung, R.D. Price, and R.D. Blakely Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells Journal of Pharmacology and Experimental Therapeutics 299 2001 666 677
3. C.L. Barr, C. Xu, J. Kroft, Y. Feng, K. Wigg, G. Zai, R. Tannock, R. Schachar, M. Malone, W. Roberts, M.M. Nothen, F. Grunhage, D.J. Vandenbergh, and G. Uhl Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder Biological Psychiatry 49 2001 333 339
4. A.L. Bauman, S. Apparsundaram, S. Ramamoorthy, B.E. Wadzinski, R.A. Vaughan, and R.D. Blakely Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A Journal of Neuroscience 20 2000 7571 7578
5. M. Cargill, D. Altshuler, J. Ireland, P. Sklar, K. Ardlie, N. Patil, C.R. Lane, E.P. Lim, N. Kalayanaraman, J. Nemesh, L. Ziaugra, L. Friedland, A. Rolfe, and J. Warrington Characterization of single-nucleotide polymorphisms in coding regions of human genes Nature Genetics 22 1999 231 238
6. A. Carneiro, S.L. Ingram, J.-M. Beaulieu, A. Sweeney, S.G. Amara, S.M. Thomas, M.G. Caron, and G.E. Torres The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter Journal of Neuroscience 22 2002 7045 7054
7. L. Carvelli, J.A. Moron, K.M. Kahlig, J.V. Ferrer, N. Sen, J.D. Lechleiter, L.M. Leeb-Lundberg, G. Merrill, E.M. Lafer, L.M. Ballou, T.S. Shippenberg, J.A. Javitch, R.Z. Lin, and A. Galli PI 3-kinase regulation of dopamine uptake Journal of Neurochemistry 81 2002 859 869
8. L. Carvelli, P.W. McDonald, R.D. Blakely, and L.J. Defelice Dopamine transporters depolarize neurons by a channel mechanism Proceedings of the National Academy of Sciences of the United States of America 101 2004 16046 16051
9. C.K. Chen, S.L. Chen, J. Mill, Y.S. Huang, S.K. Lin, S. Curran, S. Purcell, P. Sham, and P. Asherson The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample Molecular Psychiatry 8 2003 393 396
10. N.H. Chen, M.E. Reith, and M.W. Quick Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6 Pflugers Archiv: European Journal of Physiology 447 2004 519 531
11. K.A. Cheon, Y.H. Ryu, Y.K. Kim, K. Namkoong, C.H. Kim, and J.D. Lee Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder European Journal of Nuclear Medicine and Molecular Imaging 30 2003 306 311
12. E.H. Cook Jr., M.A. Stein, M.D. Krasowski, N.J. Cox, D.M. Olkon, J.E. Kieffer, and B.L. Leventhal Association of attention-deficit disorder and the dopamine transporter gene American Journal of Human Genetics 56 1995 993 998
13. S. Curran, J. Mill, E. Tahir, L. Kent, S. Richards, A. Gould, L. Huckett, J. Sharp, C. Batten, S. Fernando, F. Ozbay, Y. Yazgan, E. Simonoff, and M. Thompson Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples Molecular Psychiatry 6 2001 425 428
14. G. Daly, Z. Hawi, M. Fitzgerald, and M. Gill Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Molecular Psychiatry 4 1999 192 196
15. D.D. Dougherty, A.A. Bonab, T.J. Spencer, S.L. Rauch, B.K. Madras, and A.J. Fischman Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 354 1999 2132 2133
16. S. Dresel, J. Krause, K.H. Krause, C. LaFougere, K. Brinkbaumer, H.F. Kung, K. Hahn, and K. Tatsch Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment European Journal of Nuclear Medicine 27 2000 1518 1524
17. R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, E.D. Levin, M. Jaber, and M.G. Caron Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 1999 397 401
18. M. Gill, G. Daly, S. Heron, Z. Hawi, and M. Fitzgerald Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Molecular Psychiatry 2 1997 311 313
19. B. Giros, S. El Mestikawy, N. Godinot, K. Zheng, H. Han, T. Yang-Feng, and M.G. Caron Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Molecular Pharmacology 42 1992 383 390
20. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
21. C. Granas, J. Ferrer, C.J. Loland, J.A. Javitch, and U. Gether N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization Journal of Biological Chemistry 278 2003 4990 5000
22. F. Grunhage, T.G. Schulze, D.J. Muller, M. Lanczik, E. Franzek, M. Albus, M. Borrmann-Hassenbach, M. Knapp, S. Cichon, W. Maier, M. Rietschel, P. Propping, and M.M. Nothen Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) Molecular Psychiatry 5 2000 275 282
23. M.K. Hahn, and R.D. Blakely Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders The Pharmacogenomics Journal 2 2002 217 235
24. M.K. Hahn, D. Robertson, and R.D. Blakely A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters Journal of Neuroscience 23 2003 4470 4478
25. M.K. Hahn, M. Mazei-Robison, and R.D. Blakely Single nucleotide polymorphisms in the human norepinephrine transporter gene impact expression, trafficking, antidepressant interaction and protein kinase C regulation Molecular Pharmacology 68 2005 457 466
26. H. Hastrup, A. Karlin, and J.A. Javitch Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment Proceedings of the National Academy of Sciences of the United States of America 98 2001 10055 10060
27. J. Holmes, A. Payton, J.H. Barrett, T. Hever, H. Fitzpatrick, A.L. Trumper, R. Harrington, P. McGuffin, M. Owen, W. Ollier, J. Worthington, and A. Thapar A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder Molecular Psychiatry 5 2000 523 530
28. L.D. Jayanthi, D.J. Samuvel, R.D. Blakely, and S. Ramamoorthy Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation Molecular Pharmacology 67 2005 2077 2087
29. S.R. Jones, R.R. Gainetdinov, X.T. Hu, D.C. Cooper, R.M. Wightman, F.J. White, and M.G. Caron Loss of autoreceptor functions in mice lacking the dopamine transporter Nature Neuroscience 2 1999 649 655
30. H. Khoshbouei, N. Sen, B. Guptaroy, L. Johnson, D. Lund, M.E. Gnegy, A. Galli, and J.A. Javitch N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux PLoS Biology 2 2004 E78
31. F. Kilic, D.L. Murphy, and G. Rudnick A human serotonin transporter mutation causes constitutive activation of transport activity Molecular Pharmacology 64 2003 440 446
32. K.H. Krause, S.H. Dresel, J. Krause, H.F. Kung, and K. Tatsch Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography Neuroscience Letters 285 2000 107 110
33. K.H. Lee, M.Y. Kim, D.H. Kim, and Y.S. Lee Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter Neurochemical Research 29 2004 1405 1409
34. L.B. Li, N. Chen, S. Ramamoorthy, L. Chi, X.N. Cui, L.C. Wang, and M.E. Reith The role of N-glycosylation in function and surface trafficking of the human dopamine transporter Journal of Biological Chemistry 279 2004 21012 21020
35. Z. Lin, and G.R. Uhl Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities The Pharmacogenomics Journal 3 2003 159 168
36. Z. Lin, P.W. Zhang, X. Zhu, J.M. Melgari, R. Huff, R.L. Spieldoch, and G.R. Uhl Phosphatidylinositol 3-kinase, protein kinase C, and MEK1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites Journal of Biological Chemistry 278 2003 20162 20170
37. M.K. Loder, and H.E. Melikian The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines Journal of Biological Chemistry 278 2003 22168 22174
38. C.J. Loland, L. Norregaard, T. Litman, and U. Gether Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle Proceedings of the National Academy of Sciences of the United States of America 99 2002 1683 1688
39. Mazei-Robison, M.S., Couch, R.S., Shelton, R.C., Stein, M.A., Blakely, R.D., 2005. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49 (6) 724-736.
40. H. Melikian, and K. Buckley Membrane trafficking regulates the activity of the human dopamine transporter Journal of Neuroscience 19 1999 7699 7710
41. J.A. Moron, I. Zakharova, J.V. Ferrer, G.A. Merrill, B. Hope, E.M. Lafer, Z.C. Lin, J.B. Wang, J.A. Javitch, A. Galli, and T.S. Shippenberg Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity Journal of Neuroscience 23 2003 8480 8488
42. N. Ozaki, D. Goldman, W.H. Kaye, K. Plotnicov, B.D. Greenberg, J. Lappalainen, G. Rudnick, and D.L. Murphy Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype Molecular Psychiatry 8 895 2003 933 936
43. C.G. Palmer, J.N. Bailey, C. Ramsey, D. Cantwell, J.S. Sinsheimer, M. Del'Homme, J. McGough, J.A. Woodward, R. Asarnow, J. Asarnow, S. Nelson, and S.L. Smalley No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample Psychiatric Genetics 9 1999 157 160
44. Prasad, H.C., Zhu, C.B., McCauley, J.L., Samuvel, D.J., Ramamoorthy, S., Shelton, R.C., Sutcliffe, J.S., Blakely, R.D., 2005. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proceedings of the National Academy of Sciences of the United States of America 102, 11545-11550.
45. V. Sandoval, G.E. Torres, A.R. Meloni, and M.G. Caron Regulation of the dopamine transporter by calmodulin 2003 Society for Neuroscience
46. C. Saunders, J.V. Ferrer, L. Shi, J. Chen, G. Merrill, M.E. Lamb, L.M. Leeb-Lundberg, L. Carvelli, J.A. Javitch, and A. Galli Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism Proceedings of the National Academy of Sciences of the United States of America 97 2000 6850 6855
47. A. Schmidt, M.J. Hannah, and W.B. Huttner Synaptic-like microvesicles of neuroendocrine cells originate from a novel compartment that is continuous with the plasma membrane and devoid of transferrin receptor Journal of Cell Biology 137 1997 445 458
48. J.R. Shannon, N.L. Flattem, J. Jordan, G. Jacob, B.K. Black, I. Biaggioni, R.D. Blakely, and D. Robertson Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency New England Journal of Medicine 342 2000 541 549
49. M.S. Sonders, S.J. Zhu, N.R. Zahniser, M.P. Kavanaugh, and S.G. Amara Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants Journal of Neuroscience 17 1997 960 974
50. C. Spielewoy, C. Roubert, M. Hamon, M. Nosten-Bertrand, C. Betancur, and B. Giros Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice Behavioural Pharmacology 11 2000 279 290
51. R.D. Todd, Y.J. Jong, E.A. Lobos, W. Reich, A.C. Heath, and R.J. Neuman No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins American Journal of Medical Genetics 105 2001 745 748
52. G.E. Torres, W.D. Yao, R.R. Mohn, H. Quan, K. Kim, A.I. Levey, J. Staudinger, and M.G. Caron Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1 Neuron 30 2001 121 134
53. G.E. Torres, A. Carneiro, K. Seamans, C. Fiorentini, A. Sweeney, W.D. Yao, and M.G. Caron Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter Journal of Biological Chemistry 278 2003 2731 2739
54. J. Uchida, Y. Kiuchi, M. Ohno, A. Yura, and K. Oguchi Ca(2+)-dependent enhancement of [3H]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases Brain Research 809 1998 155 164
55. D.J. Vandenbergh, M.D. Thompson, E.H. Cook, E. Bendahhou, T. Nguyen, M.D. Krasowski, D. Zarrabian, D. Comings, E.M. Sellers, R.F. Tyndale, S.R. George, B.F. O'Dowd, and G.R. Uhl Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations Molecular Psychiatry 5 2000 283 292
56. R.A. Vaughan Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters Journal of Pharmacology and Experimental Therapeutics 310 2004 1 7
57. I.D. Waldman, D.C. Rowe, A. Abramowitz, S.T. Kozel, J.H. Mohr, S.L. Sherman, H.H. Cleveland, M.L. Sanders, J.M. Gard, and C. Stever Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity American Journal of Human Genetics 63 1998 1767 1776
58. C.B. Zhu, W.A. Hewlett, I. Feoktistov, I. Biaggioni, and R.D. Blakely Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation Molecular Pharmacology 65 2004 1462 1474
59. C.B. Zhu, A.M. Carneiro, W.R. Dostmann, W.A. Hewlett, and R.D. Blakely p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process Journal of Biological Chemistry 280 2005 15649 15658